tolvaptan has been researched along with Genetic Predisposition in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukami, K; Hazama, T; Ito, S; Kaida, Y; Koda, Y; Kodama, G; Kurokawa, Y; Moriyama, T; Nakamura, N; Nakayama, Y; Ota, K; Shibata, R; Soejima, M; Takamiya, Y; Ueda, U; Yano, J; Yokota, Y | 1 |
| Goggolidou, P; Malik, SA; Modarage, K; Richards, T | 1 |
1 review(s) available for tolvaptan and Genetic Predisposition
| Article | Year |
|---|---|
The cellular pathways and potential therapeutics of Polycystic Kidney Disease.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Genetic Predisposition to Disease; Humans; Kidney; Mutation; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Signal Transduction; Tolvaptan | 2021 |
1 other study(ies) available for tolvaptan and Genetic Predisposition
| Article | Year |
|---|---|
Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Female; Genetic Predisposition to Disease; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Mutation; Polycystic Kidney, Autosomal Dominant; Recovery of Function; Retrospective Studies; Time Factors; Tolvaptan; Tomography, X-Ray Computed; Treatment Outcome; TRPP Cation Channels | 2021 |